IN THE Byzantine world of US pharmaceutical intellectual property (IP) rights, which has a model that is exported to and imposed in most parts of the world, the twists and turns in the case of Moderna's patent claims on its vaccine are riveting. Moderna is one of two startups—the other being BioNTech of Germany that has tied up with Pfizer—to have developed the new-tech messenger RNA or mRNA vaccines against SARS-COV-2. During the pandemic, these companies have become the stars of the fight against the lethal virus, even though AstraZeneca's traditional vaccine has done most of the heavy lifting.
But Moderna's COVID-19 vaccine has been caught up in controversies and, now, lawsuits over its patents. One reason for this is the huge helping hand it received from government scientists of the National Institutes of Health (NIH), in getting both the technology rights as well as the funds running into billions of dollars. Yet it excluded NIH scientists as co-inventors when it sought four patents on the vaccine (see 'Moderna's brazen patent grab on COVID-19 jab', Down To Earth 1-15 December 2021).
Diese Geschichte stammt aus der March 16, 2022-Ausgabe von Down To Earth.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der March 16, 2022-Ausgabe von Down To Earth.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.